Literature DB >> 30190841

Spitzoid melanoma of childhood: a case series and review.

Sandeep Batra1,2,3,1.   

Abstract

Spitzoid melanomas (SM) and atypical Spitz tumors (AST) are rare pediatric neoplasms. We performed a retrospective, single-institution review and report our institutional experience. We identified 10 patients (median age: 12.5 years). A sentinel node biopsy (SNB) was performed in 8/10 (80%) patients, and interestingly 7/8 (87.5%) were found to be positive for malignant cells. A complete regional lymphadenectomy was performed in all SNB-positive patients, but only 2/8 (25%) were found to have additional lymph node spread. Adjuvant therapy was administered in 5/8 SLNB-positive and 2/2 (100%) regional LN-positive cases. All patients had excellent long-term outcomes (100% survival). This report highlights the excellent outcomes associated with SNB + pediatric SM and AST.

Entities:  

Keywords:  Spitzoid melanoma; long-term survival; lymph node metastasis; sentinel lymph node biopsy; variants

Year:  2015        PMID: 30190841      PMCID: PMC6094708          DOI: 10.2217/mmt.15.6

Source DB:  PubMed          Journal:  Melanoma Manag        ISSN: 2045-0885


  44 in total

1.  Alterations of 9p21 analysed by FISH and MLPA distinguish atypical spitzoid melanocytic tumours from conventional Spitz's nevi but do not predict their biological behaviour.

Authors:  Anna Maria Cesinaro; Laura Schirosi; Stefania Bettelli; Mario Migaldi; Antonio Maiorana
Journal:  Histopathology       Date:  2010-09-22       Impact factor: 5.087

2.  High prevalence of angiotropism in congenital melanocytic nevi: an analysis of 53 cases.

Authors:  Victor Kokta; Tawny Hung; Rola Al Dhaybi; Claire Lugassy; Raymond L Barnhill
Journal:  Am J Dermatopathol       Date:  2013-04       Impact factor: 1.533

3.  Spitz nevus versus spitzoid melanoma: diagnostic difficulties, conceptual controversies.

Authors:  Wolter J Mooi; T Krausz
Journal:  Adv Anat Pathol       Date:  2006-07       Impact factor: 3.875

4.  Sentinel lymph node biopsy in pediatric and adolescent patients: a proven technique.

Authors:  Robert Howman-Giles; Roger F Uren; John Thompson
Journal:  Ann Surg       Date:  2014-06       Impact factor: 12.969

5.  Is pediatric melanoma always malignant?

Authors:  Daniel G Coit; Marc S Ernstoff; Klaus J Busam
Journal:  Cancer       Date:  2013-09-10       Impact factor: 6.860

6.  PD-L1 expression in melanocytic lesions does not correlate with the BRAF V600E mutation.

Authors:  Nemanja Rodić; Robert A Anders; James R Eshleman; Ming-Tseh Lin; Haiying Xu; Jung H Kim; Katie Beierl; Shuming Chen; Brandon S Luber; Hao Wang; Suzanne L Topalian; Drew M Pardoll; Janis M Taube
Journal:  Cancer Immunol Res       Date:  2014-11-04       Impact factor: 11.151

7.  Sentinel node biopsy in atypical melanocytic neoplasms in childhood: a single institution experience in 24 patients.

Authors:  Omie L Mills; Suroosh Marzban; Jonathan S Zager; Vernon K Sondak; Jane L Messina
Journal:  J Cutan Pathol       Date:  2012-03       Impact factor: 1.587

Review 8.  The immune escape in melanoma: role of the impaired dendritic cell function.

Authors:  Marco Tucci; Stefania Stucci; Anna Passarelli; Giuseppe Giudice; Franco Dammacco; Franco Silvestris
Journal:  Expert Rev Clin Immunol       Date:  2014-09-02       Impact factor: 4.473

9.  PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics.

Authors:  D Massi; D Brusa; B Merelli; M Ciano; V Audrito; S Serra; R Buonincontri; G Baroni; R Nassini; D Minocci; L Cattaneo; E Tamborini; A Carobbio; E Rulli; S Deaglio; M Mandalà
Journal:  Ann Oncol       Date:  2014-09-15       Impact factor: 32.976

10.  The immune-related role of BRAF in melanoma.

Authors:  Sara Tomei; Davide Bedognetti; Valeria De Giorgi; Michele Sommariva; Sara Civini; Jennifer Reinboth; Muna Al Hashmi; Maria Libera Ascierto; Qiuzhen Liu; Ben D Ayotte; Andrea Worschech; Lorenzo Uccellini; Paolo A Ascierto; David Stroncek; Giuseppe Palmieri; Lotfi Chouchane; Ena Wang; Francesco M Marincola
Journal:  Mol Oncol       Date:  2014-08-06       Impact factor: 6.603

View more
  1 in total

Review 1.  The Spectrum of Spitz Melanocytic Lesions: From Morphologic Diagnosis to Molecular Classification.

Authors:  Tiffany W Cheng; Madeline C Ahern; Alessio Giubellino
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.